Miyoshi America, Inc. entered Chapter 11 in the Southern District of Texas with the unusual posture of a case whose votes were already counted and whose central bargain was already struck. The petition was filed on April 27, 2026, the same day the voting deadline closed on a plan that had been solicited from creditors more than a month earlier. The combined hearing to approve the disclosure statement and confirm the plan is scheduled for June 3, 2026, with an outside confirmation deadline of June 15.

On the numbers, the path to confirmation looks clear. The class holding the talc personal injury claims voted to accept by more than 99 percent in both amount and number, the parent company that holds the only other voting claim accepted unanimously, and no party filed an objection of any kind by the May 19 deadline. Two contingencies remain. The Debtor has agreed to file a modified plan that addresses U.S. Trustee feedback on the release, exculpation, and injunction provisions before the combined hearing. And the channeling injunction that sits at the center of the plan cannot take effect on confirmation alone: it requires affirmance by the district court in addition to the bankruptcy court. If either court declines, the effective date does not occur.

Miyoshi America processes and sells specialized cosmetic ingredients, including pigments, composites, and substrates, to cosmetic manufacturers. It operates from an owned headquarters in Dayville, Connecticut and leases a laboratory and sales office in Valley Cottage, New York. The company is incorporated in Texas, where it began in 1985 as U.S. Cosmetics Corp., merged with Miki America, Inc. in 1997, and took its current name in 2016.

The corporate structure matters to how this case is built. Miyoshi America runs as a standalone business with its own board of directors and independent management, but it is wholly owned by Miyoshi Kasei, Inc., a non-debtor Japanese affiliate. That parent is the source of nearly every dollar in the restructuring. The company also entered distress without significant funded debt. It historically carried none and generally covered operations from cash flow. The debt that exists today is recent, arising from the intercompany financing the parent advanced as the litigation pressure mounted.

The company has been named as a defendant in talc personal injury lawsuits since 2018, but the filings tell a story of acceleration rather than a steady burden. Five cases were filed in 2022. By 2025 the figure had reached 167. More than 200 cases were pending as of the petition date, predominantly alleging mesothelioma or similar injuries from talc said to have been contaminated with asbestos.

The product at the heart of the litigation was never a large part of the business. Surface-treated talc-based ingredients accounted for roughly 5 percent of historical sales, and the Debtor discontinued the line in 2025, about a year before filing. The Debtor maintains that none of its products were ever contaminated with asbestos. That position does not resolve the economics. The volume of claims, the ad hoc settlements they generated, and the steadily rising cost of mounting a defense had become, in the company's description, unsustainable. Absent a plan, the Debtor indicates it would likely face liquidation under the weight of defending a growing docket of claims.

Section 524(g) of the Bankruptcy Code lets a company facing asbestos-related liabilities route present and future claims into a dedicated trust and obtain a channeling injunction that directs claimants to that trust as their sole recourse. The mechanism exists because asbestos claims surface over long latency periods, which makes future claimants impossible to identify and ordinary settlement impossible to finalize. The trust gives the debtor and a defined set of protected parties finality, and it gives future claimants a funded source of recovery that does not depend on a race to the courthouse.

What makes this case notable is the packaging. The Debtor describes this one as a first-of-its-kind prepackaged plan under Section 524(g), with creditor votes solicited before the petition was ever filed. That posture rests on more than six months of arm's-length negotiation conducted before filing among the Debtor, its parent, an ad hoc committee of plaintiffs' law firms representing the vast majority of claim holders, and a prepetition future claimants' representative tasked with protecting claimants who do not yet know they will have a claim.

The plan would establish a talc personal injury trust funded primarily by the parent company. The headline contribution is a $19 million cash payment on the effective date, drawn from a $20 million contribution that the parent would make to the reorganized company. A $1 million promissory note follows, non-interest-bearing and maturing six months after the effective date. The note is small in dollars but structurally important: it is secured by a first-priority lien on 50.1 percent of the reorganized company's equity, so a payment default would let the trust take majority ownership of the business, including its voting rights.

A trustee would manage the trust, overseen by an advisory committee of claim-holder representatives and a post-effective-date future claimants' representative. Distribution procedures would set medical and exposure criteria and a range of liquidated values that distinguish mesothelioma claims from other disease claims, with claims processed on a first-in, first-out basis and similar claims treated substantially the same. A payment percentage, the share of liquidated value a claimant actually receives, would be set by the trustee with the consent of the advisory committee and the post-effective-date future claimants' representative, and re-evaluated at least once every three years as the trust's assets and the claim population evolve.

The reason the parent dominates the capital structure is that nobody else would step in. In May and June of 2025, the Debtor's investment banker contacted roughly 17 third-party financial institutions about prepetition financing. None produced actionable interest, which the banker attributes to two factors: the uncertainty of the litigation and the absence of any framework for resolving the claims.

When the banker returned to the market in February 2026, the resolution framework existed, and interest improved, but only marginally. Of 11 prospects, two submitted term sheets. Both were deemed expensive and non-advantageous, neither offered to lend on an unsecured or junior basis or to engage in a priming fight, and neither provided enough financing to refinance the prepetition loan. The parent, for its part, would not consent to any financing that primed or sat alongside its existing collateral. That left the parent's own $20 million DIP facility at 7.50 percent as the only viable option. The exit financing carries that logic forward on better terms for the company.

The structure protects two things at once. The reduced rate, the 24-month paid-in-kind period, and the payment conditions tied to income and cash flow preserve the reorganized company's liquidity as it stabilizes without its talc litigation burden. The subordination protects the trust: the parent's own exit loan cannot be repaid until the trust note is satisfied in full, which keeps the parent's recovery behind the claimants the trust is built to pay.

Because the plan was solicited before filing, the vote is already complete. Solicitation began on March 13, 2026, with packages sent by overnight delivery to the attorneys representing every holder of a pending talc claim. The record date was March 27, the voting deadline was April 27, and the solicitation period ran roughly 45 days. No individual ballots were ultimately used, because every known holder was represented by counsel who submitted master ballots on their behalf.

The class holding the talc claims accepted by more than 99 percent in both amount and number, with a nominal $1 value assigned to each claim solely for voting. The parent, as the sole holder of the prepetition financing claim, accepted unanimously. The only class treated as a rejecting class is the existing equity, which is deemed to reject because it receives nothing on account of its old interests, but its sole holder is the parent, which proposed the plan and supports it. The Debtor seeks to confirm over that deemed rejection through cramdown.

The plan leaves most creditor classes untouched and concentrates impairment in the two classes tied directly to the restructuring. Trade and ordinary creditors are paid in full, the talc claims are channeled to the trust, and the parent absorbs both the financing claim and the equity.

The unimpaired classes, including priority, secured, general unsecured, and intercompany claims, are slated for full recovery. The recovery to talc claimants will depend on the trust's assets and the payment percentage its trustee sets over time, which is why the plan does not assign those claims a fixed percentage. The parent's recovery sits last, behind both the trust and the unimpaired creditors.

The legal architecture of the plan turns on a small number of questions, and the Debtor's confirmation brief is organized to answer each. The threshold issue is whether the trust satisfies Section 524(g) itself. The plan argues that it meets all four funding requirements, including the requirement that the trust hold the right to own a majority of the reorganized company's voting shares on specified contingencies, which the 50.1 percent equity pledge is designed to satisfy. It also argues that the factual predicates are met, among them the long latency of asbestos claims, the risk that pursuit outside the plan would impair equitable distribution, and the statutory requirement that the injunction be approved by a class vote of at least 75 percent. The 99 percent acceptance clears that bar comfortably.

A second question is who the injunction protects. The parent is not the debtor, so it must independently qualify for protection under the statute. The plan asserts three independent grounds: the parent's 100 percent ownership of the Debtor, its involvement in management and as a director, and its provision of financing. Any one of the three would suffice; the plan rests on all three.

The remaining issues are more routine for a plan with this level of support. Cramdown of the equity class rests on the absence of any class junior to it, which the plan argues satisfies the absolute priority rule. Exculpation is framed narrowly, covering only parties that participated in the restructuring and excluding fraud, willful misconduct, and gross negligence. And the market test described earlier does double duty as a legal argument: the banker's outreach to roughly 17 institutions for prepetition financing and 11 for the DIP, yielding no viable alternative, is offered as evidence that the parent's financing was the only realistic option and was negotiated at arm's length.

The near-term calendar is short and specific. A modified plan responding to the U.S. Trustee's feedback is expected before the combined hearing. The combined hearing on disclosure-statement adequacy and confirmation is set for June 3, with an outside confirmation deadline of June 15 that the parties built in as a condition for waiving the meeting of creditors and the schedules and statement of financial affairs.

If the plan is confirmed and affirmed as proposed, the reorganized company emerges intact: roughly 62 jobs preserved, the talc product line gone, and the talc liability routed away from the business and into a funded trust. The parent would hold 100 percent of the reorganized equity, but subject to the pledge that lets the trust take majority control on a payment default, and its own exit loan would sit behind the trust note in priority. Claimants would look to the trust rather than to the courthouse, with recoveries set by a payment percentage that the trustee adjusts over time.